Corcept Therapeutics, Inc. (CORT)
70.20
-9.62
(-12.06%)
USD |
NASDAQ |
Dec 30, 16:00
70.14
-0.06
(-0.08%)
After-Hours: 20:00
Corcept Therapeutics Market Cap: 7.384B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 498.51B |
| United Therapeutics Corp. | 21.36B |
| Amgen, Inc. | 176.99B |
| Vertex Pharmaceuticals, Inc. | 115.12B |
| Theravance Biopharma, Inc. | 958.22M |
Market Cap Related Metrics
| PE Ratio | 80.20 |
| PS Ratio | 11.32 |
| Price to Book Value | 11.68 |
| Price to Free Cash Flow | 51.62 |
| Price | 70.20 |
| Earnings Yield | 1.25% |
| Operating PE Ratio | 127.98 |
| Normalized PE Ratio | 80.20 |